formulation

Domp’s Program in NAION Selected for Landmark FDA Commissioners National Priority Voucher Program

One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication…

6 days ago

Milliken & Company Launches Millad ClearX 9000: The Clear Choice for Polypropylene

Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers SPARTANBURG, S.C.,…

2 weeks ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

1 month ago

PPG launches PPG HI-GARD Non-Methanol hard coating for ophthalmic lenses

Works with existing systems, helps lens makers stay ahead of global regulationsPITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced the launch of PPG…

1 month ago

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE

Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…

5 months ago